跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Amino Acid(16AA), Glucose(12.6%) and Electrolyte Injection
Approved
化学药品
Compound Amino Acid(16AA), Glucose(12.6%) and Electrolyte Injection
Fresenius Kabi Austria Gmbh
🇨🇳 National Medical Products Administration
Approval Date
Jun 7, 2023
Approval ID
8TEMLFx0uMv
Company
Fresenius Kabi Austria Gmbh
Type
化学药品
Approval Details
Approval Id
8TEMLFx0uMv
Approval Number
国药准字HJ20230062
Generic Name
复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液
Generic Name En
Compound Amino Acid(16AA), Glucose(12.6%) and Electrolyte Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
1000ml[复方氨基酸(16AA)电解质注射液500ml;葡萄糖注射液(12.6%)500ml]
Reg Date
2023-06-07
Expired Date
2028-06-06
Company Name
Fresenius Kabi Austria Gmbh
Production Company Name
Fresenius Kabi Austria Gmbh
Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Production Company Detail Path
/organization/fresenius-kabi-austria-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 7, 2023
Approval ID
8TEMLFx0uMv
Type
化学药品
Back to NMPA Approvals